Ruihao Huang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Respiratory Syndrome Coronavirus

Machine Learning

Top Venues

Clinical pharmacology and therapeutics

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Liu, Raj Nair, Ruihao Huang, Hao Zhu, Austin Anderson, Ozlem Belen, Van Tran, Rebecca Chiu, Karen M Higgins, Jianmeng Chen, Lei He, Suresh Doddapaneni, Shiew Mei Huang, Nikolay P Nikolov, Issam Zineh
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization. Clinical pharmacology and therapeutics 115 (4) (2024)
Qi Liu, Raj Nair, Ruihao Huang, Hao Zhu, Austin Anderson, Ozlem Belen, Van Tran, Rebecca Chiu, Karen M Higgins, Jianmeng Chen, Lei He, Suresh Doddapaneni, Shiew Mei Huang, Nikolay P Nikolov, Issam Zineh
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization. Clinical pharmacology and therapeutics (2024)
Qi Liu, Raj Nair, Ruihao Huang, Hao Zhu, Austin Anderson, Ozlem Belen, Van Tran, Rebecca Chiu, Karen M Higgins, Jianmeng Chen, Lei He, Suresh Doddapaneni, Shiew Mei Huang, Nikolay P Nikolov, Issam Zineh
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization. Clinical pharmacology and therapeutics 115 (4) (2024)
Qi Liu, Raj Nair, Ruihao Huang, Hao Zhu, Austin Anderson, Ozlem Belen, Van Tran, Rebecca Chiu, Karen M Higgins, Jianmeng Chen, Lei He, Suresh Doddapaneni, Shiew Mei Huang, Nikolay P Nikolov, Issam Zineh
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization. Clinical pharmacology and therapeutics 115 (4) (2024)
Qi Liu, Raj Nair, Ruihao Huang, Hao Zhu, Austin Anderson, Ozlem Belen, Van Tran, Rebecca Chiu, Karen M Higgins, Jianmeng Chen, Lei He, Suresh Doddapaneni, Shiew Mei Huang, Nikolay P Nikolov, Issam Zineh
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization. Clinical pharmacology and therapeutics 115 (4) (2024)
Qi Liu, Chenan Zhang, Yue Huang, Ruihao Huang, Shiew Mei Huang, Erin Larkins, Liza Stapleford, Donna R Rivera, Paul G Kluetz, Shenggang Wang, Hao Zhu, James L Weese, Elizabeth Cromartie, Mahder Teka, Sheetal Walters, Frank M Wolf, Thomas D Brown
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data. Cancer research communications 3 (2) (2023)
Thibaud Coroller, Berkman Sahiner, Anup Amatya, Alexej Gossmann, Konstantinos Karagiannis, Conor Moloney, Ravi K Samala, Luis Santana-Quintero, Nadia Solovieff, Craig Wang, Laleh Amiri-Kordestani, Qian Cao, Kenny H Cha, Rosane Charlab, Frank H Cross, Tingting Hu, Ruihao Huang, Jeffrey Kraft, Peter Krusche, Yutong Li, Zheng Li, Ilya Mazo, Rahul Paul, Susan Schnakenberg, Paolo Serra, Sean Smith, Chi Song, Fei Su, Mohit Tiwari, Colin Vechery, Xin Xiong, Juan Pablo Zarate, Hao Zhu, Arunava Chakravartty, Qi Liu, David Ohlssen, Nicholas Petrick, Julie A Schneider, Mark Walderhaug, Emmanuel Zuber
Methodology for good machine learning with multi-omics data. Clinical pharmacology and therapeutics (2023)
Qi Liu, Chenan Zhang, Yue Huang, Ruihao Huang, Shiew Mei Huang, Erin Larkins, Liza Stapleford, Donna R Rivera, Paul G Kluetz, Shenggang Wang, Hao Zhu, James L Weese, Elizabeth Cromartie, Mahder Teka, Sheetal Walters, Frank M Wolf, Thomas D Brown
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data. Cancer research communications 3 (2) (2023)